Radiotherapy Combined with PD-1 Inhibition Increases NK Cell Cytotoxicity towards Nasopharyngeal Carcinoma Cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Radiotherapy Combined with PD-1 Inhibition Increases NK Cell Cytotoxicity towards Nasopharyngeal Carcinoma Cells
Authors
Keywords
-
Journal
Cells
Volume 10, Issue 9, Pages 2458
Publisher
MDPI AG
Online
2021-09-18
DOI
10.3390/cells10092458
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic significance of tumor-infiltrating lymphocytes and macrophages in nasopharyngeal carcinoma: a systematic review and meta-analysis
- (2021) Weixing Liu et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Anti-PD-1 antibody increases NK cell cytotoxicity towards nasopharyngeal carcinoma cells in the context of chemotherapy-induced upregulation of PD-1 and PD-L1
- (2020) Anna Makowska et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
- (2020) Yu-Pei Chen et al. CELL RESEARCH
- Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy
- (2020) Cai Zhang et al. Frontiers in Immunology
- Immunomodulation of NK Cells by Ionizing Radiation
- (2020) Jiarui Chen et al. Frontiers in Oncology
- Identification of tumor-infiltrating immune cells and microenvironment-relevant genes in nasopharyngeal carcinoma based on gene expression profiling
- (2020) Zhenning Zou et al. LIFE SCIENCES
- Interferon beta increases NK cell cytotoxicity against tumor cells in patients with nasopharyngeal carcinoma via tumor necrosis factor apoptosis-inducing ligand
- (2019) Anna Makowska et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Ionizing radiation effects on the tumor microenvironment
- (2019) Luigi Portella et al. SEMINARS IN ONCOLOGY
- Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer
- (2019) Kazue Yoneda et al. BRITISH JOURNAL OF CANCER
- Interferon β and Anti-PD-1/PD-L1 Checkpoint Blockade Cooperate in NK Cell-Mediated Killing of Nasopharyngeal Carcinoma Cells
- (2019) Anna Makowska et al. Translational Oncology
- Immune Checkpoint Inhibitor Nivolumab and Radiotherapy in Pretreated Lung Cancer Patients
- (2018) Francesco Fiorica et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma
- (2018) Juan Lu et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic Epstein–Barr virus reactivation
- (2018) Yim Ling Yip et al. LABORATORY INVESTIGATION
- Interferon beta induces apoptosis in nasopharyngeal carcinoma cells via the TRAIL-signaling pathway
- (2018) Anna Makowska et al. Oncotarget
- CD8 + T cells and NK cells: parallel and complementary soldiers of immunotherapy
- (2018) Jillian Rosenberg et al. Current Opinion in Chemical Engineering
- Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes
- (2017) Li Zhang et al. MOLECULAR CANCER RESEARCH
- Nasopharyngeal carcinoma
- (2016) Melvin L K Chua et al. LANCET
- Chloroquine Sensitizes Nasopharyngeal Carcinoma Cells but Not Nasoepithelial Cells to Irradiation by Blocking Autophagy
- (2016) Anna Makowska et al. PLoS One
- Radiation-induced modulation of immunogenic genes in tumor cells is regulated by both histone deacetylases and DNA methyltransferases
- (2015) ERCAN CACAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- FAS Death Receptor: A Breast Cancer Subtype-Specific Radiation Response Biomarker and Potential Therapeutic Target
- (2015) Janet K. Horton et al. RADIATION RESEARCH
- Impact of late toxicities on quality of life for survivors of nasopharyngeal carcinoma
- (2014) Wen-Ling Tsai et al. BMC CANCER
- Low-Dose Ionizing Radiation Induces Direct Activation of Natural Killer Cells and Provides a Novel Approach for Adoptive Cellular Immunotherapy
- (2014) Guozi Yang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade
- (2014) S. J. Dovedi et al. CANCER RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The Effect of Radiation on the Immune Response to Cancers
- (2014) Bonggoo Park et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
- (2014) Liufu Deng et al. JOURNAL OF CLINICAL INVESTIGATION
- Treatment of Nasopharyngeal Carcinoma Cells with the Histone-Deacetylase Inhibitor Abexinostat: Cooperative Effects with Cis-platin and Radiotherapy on Patient-Derived Xenografts
- (2014) Mélanie Gressette et al. PLoS One
- Radiation-Induced Equilibrium Is a Balance between Tumor Cell Proliferation and T Cell-Mediated Killing
- (2013) H. Liang et al. JOURNAL OF IMMUNOLOGY
- Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults
- (2012) Martina Buehrlen et al. CANCER
- The battle against nasopharyngeal cancer
- (2012) Anne W.M. Lee et al. RADIOTHERAPY AND ONCOLOGY
- Dying cell clearance and its impact on the outcome of tumor radiotherapy
- (2012) Kirsten Lauber et al. Frontiers in Oncology
- A prospective protocol for nasopharyngeal carcinoma in children and adolescents
- (2011) Michela Casanova et al. CANCER
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now